article thumbnail

Patient experience with Social Prescribing Program in Ontario, Canada [Social determinants and vulnerable populations]

Annals of Family Medicine

Study design, setting, population Qualitative study using semi-structured interviews with 32/326 Ontarians participating in the ARC-211 randomized control trial (2019-2020). ARC: All (N=17) participants used navigation. Findings were summarized across 5 themes of access and mapped to navigator’s approaches.

Patients 130
article thumbnail

Episode 384: Antiracism in Medicine – Episode 26 – Racial and Gender Health Disparities in Youth Suicide: Part 1

The Clinical Problem Solvers

There are a growing number of Child Psychiatric Access Programs, including one in Massachusetts, which provide quick access to psychiatric consultation and facilitates referrals for accessing ongoing behavioral health care. Diversifying your mental health outreach goes hand in hand with diversifying your providers. Pediatrics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Improving Patient Communication

CDOCS

The question often becomes, how can we overcome this disparity in attitudes towards our professional network of referrals? ’ When working with a case that requires a combination of expertise from the general dentist and specialist, it is our job to be able to explain and provide understanding on all aspects of treatment.

article thumbnail

District Court Interprets EKRA

FDA Law Blog

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. The Eliminating Kickbacks in Recovery Act (“EKRA”). 18 U.S.C. § 18 U.S.C. § 18 U.S.C. § EKRA Issue.

article thumbnail

Could the Road to an AKS Violation Be Paved with Good Intentions? Pfizer Asks SCOTUS

FDA Law Blog

In June 2019, Pfizer sought an OIG advisory opinion to ensure that its proposal would not run afoul of federal law. Rather, Pfizer argues, the AKS focuses on “corrupt transactions,” such as the specific examples of “kickback, bribe, or rebate” that Congress provided. Borrasi, 639 F.3d 3d 774 (7th Cir.

article thumbnail

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

FDA Law Blog

Department of Health and Human Services (“HHS”), which reported that discounted purchases totaled $38 billion in 2020, a 27% increase compared to 2019. In fact, the Advisory Opinion was the first agency document to explicitly conclude that manufacturers are required by statute to provide 340B drugs to multiple contract pharmacies.

article thumbnail

District Court Interprets EKRA

FDA Law Blog

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. The Eliminating Kickbacks in Recovery Act (“EKRA”). 18 U.S.C. § 18 U.S.C. § 18 U.S.C. § EKRA Issue.